SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Andrea Pellagatti, Hamid Dolatshad, Bon Ham Yip, Simona Valletta, Jacqueline Boultwood, Application of genome editing technologies to the study and treatment of hematological disease, Advances in Biological Regulation, 2016, 60, 122

    CrossRef

  2. You have free access to this content2
    Yiren Qin, Wei-Qiang Gao, Concise Review: Patient-Derived Stem Cell Research for Monogenic Disorders, STEM CELLS, 2016, 34, 1
  3. 3
    Versha Prakash, Marc Moore, Rafael J Yáñez-Muñoz, Current Progress in Therapeutic Gene Editing for Monogenic Diseases, Molecular Therapy, 2016,

    CrossRef

  4. 4
    Matthew Porteus, Genome Editing: A New Approach to Human Therapeutics, Annual Review of Pharmacology and Toxicology, 2016, 56, 1, 163

    CrossRef

  5. 5
    Nina Xie, Beisha Tang, The Application of Human iPSCs in Neurological Diseases: From Bench to Bedside, Stem Cells International, 2016, 2016, 1

    CrossRef

  6. 6
    Theodore Sakellaropoulos, Junguk Hur, Ioannis N. Melas, Ellen Y. Guo, Leonidas Alexopoulos, Mohammad Bohlooly, Jane P.F. Bai, Personalized Medicine, 2016,

    CrossRef

  7. 7
    Miook Cho, Yousin Suh, Handbook of the Biology of Aging, 2016,

    CrossRef

  8. 8
    Daniele Focosi, Fabrizio Maggi, Luca Ceccherini-Nelli, Mauro Pistello, Cell therapies for treatment of human immunodeficiency virus infection, Reviews in Medical Virology, 2015, 25, 3
  9. 9
    Renee N. Cottle, Ciaran M. Lee, David Archer, Gang Bao, Controlled delivery of β-globin-targeting TALENs and CRISPR/Cas9 into mammalian cells for genome editing using microinjection, Scientific Reports, 2015, 5, 16031

    CrossRef

  10. 10
    David G Ousterout, Ami M Kabadi, Pratiksha I Thakore, Pablo Perez-Pinera, Matthew T Brown, William H Majoros, Timothy E Reddy, Charles A Gersbach, Correction of Dystrophin Expression in Cells From Duchenne Muscular Dystrophy Patients Through Genomic Excision of Exon 51 by Zinc Finger Nucleases, Molecular Therapy, 2015, 23, 3, 523

    CrossRef

  11. 11
    M. D. Hoban, G. J. Cost, M. C. Mendel, Z. Romero, M. L. Kaufman, A. V. Joglekar, M. Ho, D. Lumaquin, D. Gray, G. R. Lill, A. R. Cooper, F. Urbinati, S. Senadheera, A. Zhu, P.-Q. Liu, D. E. Paschon, L. Zhang, E. J. Rebar, A. Wilber, X. Wang, P. D. Gregory, M. C. Holmes, A. Reik, R. P. Hollis, D. B. Kohn, Correction of the sickle cell disease mutation in human hematopoietic stem/progenitor cells, Blood, 2015, 125, 17, 2597

    CrossRef

  12. 12
    Seahyoung Lee, Chang Yeon Lee, Jiyun Lee, Hyang-Hee Seo, Ki-Chul Hwang, Cut and paste the genome: Genome editing for research and therapy, Journal of Cellular Biotechnology, 2015, 1, 1, 95

    CrossRef

  13. 13
    Justin S. LaFountaine, Kristin Fathe, Hugh D.C. Smyth, Delivery and therapeutic applications of gene editing technologies ZFNs, TALENs, and CRISPR/Cas9, International Journal of Pharmaceutics, 2015, 494, 1, 180

    CrossRef

  14. 14
    Adrian Kee Keong Teo, Manoj K. Gupta, Alessandro Doria, Rohit N. Kulkarni, Dissecting diabetes/metabolic disease mechanisms using pluripotent stem cells and genome editing tools, Molecular Metabolism, 2015, 4, 9, 593

    CrossRef

  15. 15
    Nicole J. Neverman, Hannah L. Best, Sandra L. Hofmann, Stephanie M. Hughes, Experimental therapies in the neuronal ceroid lipofuscinoses, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2015, 1852, 10, 2292

    CrossRef

  16. 16
    Akitsu Hotta, Shinya Yamanaka, From Genomics to Gene Therapy: Induced Pluripotent Stem Cells Meet Genome Editing, Annual Review of Genetics, 2015, 49, 1, 47

    CrossRef

  17. 17
    Zita Garate, Oscar Quintana-Bustamante, Ana M. Crane, Emmanuel Olivier, Laurent Poirot, Roman Galetto, Penelope Kosinski, Collin Hill, Charles Kung, Xabi Agirre, Israel Orman, Laura Cerrato, Omaira Alberquilla, Fatima Rodriguez-Fornes, Noemi Fusaki, Felix Garcia-Sanchez, Tabita M. Maia, Maria L. Ribeiro, Julian Sevilla, Felipe Prosper, Shengfang Jin, Joanne Mountford, Guillermo Guenechea, Agnes Gouble, Juan A. Bueren, Brian R. Davis, Jose C. Segovia, Generation of a High Number of Healthy Erythroid Cells from Gene-Edited Pyruvate Kinase Deficiency Patient-Specific Induced Pluripotent Stem Cells, Stem Cell Reports, 2015, 5, 6, 1053

    CrossRef

  18. 18
    Joseph F. Petolino, Genome editing in plants via designed zinc finger nucleases, In Vitro Cellular & Developmental Biology - Plant, 2015, 51, 1, 1

    CrossRef

  19. 19
    Matthew H. Porteus, Genome Editing of the Blood: Opportunities and Challenges, Current Stem Cell Reports, 2015, 1, 1, 23

    CrossRef

  20. 20
    Guangbin Xia, Yuanzheng Gao, Shouguang Jin, S.H. Subramony, Naohiro Terada, Laura P.W. Ranum, Maurice S. Swanson, Tetsuo Ashizawa, Genome Modification Leads to Phenotype Reversal in Human Myotonic Dystrophy Type 1 Induced Pluripotent Stem Cell-Derived Neural Stem Cells, STEM CELLS, 2015, 33, 6
  21. 21
    Elizabeth R. Lorden, Howard M. Levinson, Kam W. Leong, Integration of drug, protein, and gene delivery systems with regenerative medicine, Drug Delivery and Translational Research, 2015, 5, 2, 168

    CrossRef

  22. 22
    Eric B. Kmiec, Is the age of genetic surgery finally upon us?, Surgical Oncology, 2015, 24, 2, 95

    CrossRef

  23. 23
    Shunya Arai, Masashi Miyauchi, Mineo Kurokawa, Modeling of hematologic malignancies by iPS technology, Experimental Hematology, 2015, 43, 8, 654

    CrossRef

  24. 24
    Lisa M. Ott de Bruin, Stefano Volpi, Kiran Musunuru, Novel Genome-Editing Tools to Model and Correct Primary Immunodeficiencies, Frontiers in Immunology, 2015, 6,

    CrossRef

  25. 25
    Giorgia Santilli, Adrian J Thrasher, Patching up hematopoietic stem cells, Nature Biotechnology, 2015, 33, 12, 1236

    CrossRef

  26. 26
    Hongmei Lisa Li, Naoko Fujimoto, Noriko Sasakawa, Saya Shirai, Tokiko Ohkame, Tetsushi Sakuma, Michihiro Tanaka, Naoki Amano, Akira Watanabe, Hidetoshi Sakurai, Takashi Yamamoto, Shinya Yamanaka, Akitsu Hotta, Precise Correction of the Dystrophin Gene in Duchenne Muscular Dystrophy Patient Induced Pluripotent Stem Cells by TALEN and CRISPR-Cas9, Stem Cell Reports, 2015, 4, 1, 143

    CrossRef

  27. You have free access to this content27
    Xiaosong Huang, Ying Wang, Wei Yan, Cory Smith, Zhaohui Ye, Jing Wang, Yongxing Gao, Laurel Mendelsohn, Linzhao Cheng, Production of Gene-Corrected Adult Beta Globin Protein in Human Erythrocytes Differentiated from Patient iPSCs After Genome Editing of the Sickle Point Mutation, STEM CELLS, 2015, 33, 5
  28. 28
    Ayal Hendel, Eli J. Fine, Gang Bao, Matthew H. Porteus, Quantifying on- and off-target genome editing, Trends in Biotechnology, 2015, 33, 2, 132

    CrossRef

  29. 29
    Young-Il Jo, Hyongbum Kim, Suresh Ramakrishna, Recent developments and clinical studies utilizing engineered zinc finger nuclease technology, Cellular and Molecular Life Sciences, 2015, 72, 20, 3819

    CrossRef

  30. 30
    Chul-Yong Park, Tomer Halevy, Dongjin R. Lee, Jin Jea Sung, Jae Souk Lee, Ofra Yanuka, Nissim Benvenisty, Dong-Wook Kim, Reversion of FMR1 Methylation and Silencing by Editing the Triplet Repeats in Fragile X iPSC-Derived Neurons, Cell Reports, 2015, 13, 2, 234

    CrossRef

  31. 31
    Hiromitsu Iizuka, Yuki Kagoya, Keisuke Kataoka, Akihide Yoshimi, Masashi Miyauchi, Kazuki Taoka, Keiki Kumano, Takashi Yamamoto, Akitsu Hotta, Shunya Arai, Mineo Kurokawa, Targeted gene correction of RUNX1 in induced pluripotent stem cells derived from familial platelet disorder with propensity to myeloid malignancy restores normal megakaryopoiesis, Experimental Hematology, 2015, 43, 10, 849

    CrossRef

  32. 32
    T. Kloskowski, M. Nowacki, M. Pokrywczyńska, T. Drewa, Urine – A waste or the future of regenerative medicine?, Medical Hypotheses, 2015, 84, 4, 344

    CrossRef

  33. 33
    Alisa Dong, Laura Breda, Stefano Rivella, Translating Gene Therapy to the Clinic, 2015,

    CrossRef

  34. 34
    Mathew G. Angelos, Fahad Kidwai, Dan S. Kaufman, Translating Gene Therapy to the Clinic, 2015,

    CrossRef

  35. 35
    Jakub Tolar, Translating Gene Therapy to the Clinic, 2015,

    CrossRef

  36. 36
    Pratiksha I. Thakore, Charles A. Gersbach, Translating Gene Therapy to the Clinic, 2015,

    CrossRef

  37. 37
    Hyongbum Kim, Jin-Soo Kim, A guide to genome engineering with programmable nucleases, Nature Reviews Genetics, 2014, 15, 5, 321

    CrossRef

  38. 38
    E. J. Fine, T. J. Cradick, C. L. Zhao, Y. Lin, G. Bao, An online bioinformatics tool predicts zinc finger and TALE nuclease off-target cleavage, Nucleic Acids Research, 2014, 42, 6, e42

    CrossRef

  39. 39
    Pengfei Liu, Yanmei Zhang, Shubin Chen, Jinglei Cai, Duanqing Pei, Application of iPS Cells in Dental Bioengineering and Beyond, Stem Cell Reviews and Reports, 2014, 10, 5, 663

    CrossRef

  40. 40
    F. Zhang, Y. Wen, X. Guo, CRISPR/Cas9 for genome editing: progress, implications and challenges, Human Molecular Genetics, 2014, 23, R1, R40

    CrossRef

  41. You have free access to this content41
    Zhaohui Ye, Cyndi F. Liu, Lucie Lanikova, Sarah N. Dowey, Chaoxia He, Xiaosong Huang, Robert A. Brodsky, Jerry L. Spivak, Josef T. Prchal, Linzhao Cheng, Differential Sensitivity to JAK Inhibitory Drugs by Isogenic Human Erythroblasts and Hematopoietic Progenitors Generated from Patient-Specific Induced Pluripotent Stem Cells, STEM CELLS, 2014, 32, 1
  42. 42
    Changsung Kim, Disease modeling and cell based therapy with iPSC: future therapeutic option with fast and safe application, Blood Research, 2014, 49, 1, 7

    CrossRef

  43. 43
    Sylvia Merkert, Stephanie Wunderlich, Christien Bednarski, Jennifer Beier, Alexandra Haase, Anne-Kathrin Dreyer, Kristin Schwanke, Johann Meyer, Gudrun Göhring, Toni Cathomen, Ulrich Martin, Efficient Designer Nuclease-Based Homologous Recombination Enables Direct PCR Screening for Footprintless Targeted Human Pluripotent Stem Cells, Stem Cell Reports, 2014, 2, 1, 107

    CrossRef

  44. 44
    Tobias Wijshake, Darren J. Baker, Bart van de Sluis, Endonucleases: new tools to edit the mouse genome, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2014, 1842, 10, 1942

    CrossRef

  45. 45
    Rajat M. Gupta, Kiran Musunuru, Expanding the genetic editing tool kit: ZFNs, TALENs, and CRISPR-Cas9, Journal of Clinical Investigation, 2014, 124, 10, 4154

    CrossRef

  46. 46
    Jered V. McGivern, Allison D. Ebert, Exploiting pluripotent stem cell technology for drug discovery, screening, safety, and toxicology assessments, Advanced Drug Delivery Reviews, 2014, 69-70, 170

    CrossRef

  47. 47
    Cyril Ramathal, Jens Durruthy-Durruthy, Meena Sukhwani, Joy E. Arakaki, Paul J. Turek, Kyle E. Orwig, Renee A. Reijo Pera, Fate of iPSCs Derived from Azoospermic and Fertile Men following Xenotransplantation to Murine Seminiferous Tubules, Cell Reports, 2014, 7, 4, 1284

    CrossRef

  48. 48
    Shanmuganathan Chandrakasan, Punam Malik, Gene Therapy for Hemoglobinopathies, Hematology/Oncology Clinics of North America, 2014, 28, 2, 199

    CrossRef

  49. 49
    Hongmei Lisa Li, Takao Nakano, Akitsu Hotta, Genetic correction using engineered nucleases for gene therapy applications, Development, Growth & Differentiation, 2014, 56, 1
  50. 50
    Dana Carroll, Genome Engineering with Targetable Nucleases, Annual Review of Biochemistry, 2014, 83, 1, 409

    CrossRef

  51. 51
    Huen Suk Kim, Jeffrey M. Bernitz, Dung-Fang Lee, Ihor R. Lemischka, Genomic Editing Tools to Model Human Diseases with Isogenic Pluripotent Stem Cells, Stem Cells and Development, 2014, 23, 22, 2673

    CrossRef

  52. 52
    Qiuhao Qu, Dong Li, Kathleen R. Louis, Xiangzhen Li, Hong Yang, Qinyu Sun, Shane R. Crandall, Stephanie Tsang, Jiaxi Zhou, Charles L. Cox, Jianjun Cheng, Fei Wang, High-efficiency motor neuron differentiation from human pluripotent stem cells and the function of Islet-1, Nature Communications, 2014, 5,

    CrossRef

  53. 53
    V. Sebastiano, H. H. Zhen, B. Haddad, E. Bashkirova, S. P. Melo, P. Wang, T. L. Leung, Z. Siprashvili, A. Tichy, J. Li, M. Ameen, J. Hawkins, S. Lee, L. Li, A. Schwertschkow, G. Bauer, L. Lisowski, M. A. Kay, S. K. Kim, A. T. Lane, M. Wernig, A. E. Oro, Human COL7A1-corrected induced pluripotent stem cells for the treatment of recessive dystrophic epidermolysis bullosa, Science Translational Medicine, 2014, 6, 264, 264ra163

    CrossRef

  54. 54
    D Focosi, G Amabile, A Di Ruscio, P Quaranta, D G Tenen, M Pistello, Induced pluripotent stem cells in hematology: current and future applications, Blood Cancer Journal, 2014, 4, 5, e211

    CrossRef

  55. 55
    A. M. Kabadi, D. G. Ousterout, I. B. Hilton, C. A. Gersbach, Multiplex CRISPR/Cas9-based genome engineering from a single lentiviral vector, Nucleic Acids Research, 2014, 42, 19, e147

    CrossRef

  56. 56
    Ke Huang, PengFei Liu, Xiang Li, ShuBin Chen, LiHui Wang, Li Qin, ZhengHui Su, WenHao Huang, JuLi Liu, Bei Jia, Jie Liu, JingLei Cai, DuanQing Pei, GuangJin Pan, Neural progenitor cells from human induced pluripotent stem cells generated less autogenous immune response, Science China Life Sciences, 2014, 57, 2, 162

    CrossRef

  57. 57
    Susan Jarmin, Hanna Kymalainen, Linda Popplewell, George Dickson, New developments in the use of gene therapy to treat Duchenne muscular dystrophy, Expert Opinion on Biological Therapy, 2014, 14, 2, 209

    CrossRef

  58. 58
    R. A. Voit, A. Hendel, S. M. Pruett-Miller, M. H. Porteus, Nuclease-mediated gene editing by homologous recombination of the human globin locus, Nucleic Acids Research, 2014, 42, 2, 1365

    CrossRef

  59. 59
    Tommaso Vannocci, Hitoshi Kurata, Josu Fuente, Irene A. Roberts, Andrew C. G. Porter, Nuclease-stimulated homologous recombination at the human β-globin gene, The Journal of Gene Medicine, 2014, 16, 1-2
  60. 60
    Alessia Finotti, Roberto Gambari, Recent trends for novel options in experimental biological therapy of β-thalassemia, Expert Opinion on Biological Therapy, 2014, 14, 10, 1443

    CrossRef

  61. You have free access to this content61
    Ning Sun, Huimin Zhao, Seamless correction of the sickle cell disease mutation of the HBB gene in human induced pluripotent stem cells using TALENs, Biotechnology and Bioengineering, 2014, 111, 5
  62. 62
    J.-A. Talano, M. S. Cairo, Smoothing the crescent curve: sickle cell disease, Hematology, 2014, 2014, 1, 468

    CrossRef

  63. 63
    D. V. Glazkova, G. A. Shipulin, TALE nucleases as a new tool for genome editing, Molecular Biology, 2014, 48, 3, 305

    CrossRef

  64. 64
    Nigel G. Kooreman, Julia D. Ransohoff, Joseph C. Wu, Tracking gene and cell fate for therapeutic gain, Nature Materials, 2014, 13, 2, 106

    CrossRef

  65. 65
    Muhammad Saad Farooq, Muhammad Zain Farooq, Zinc-finger Nucleases and Their Application in the Treatment of Genetic Diseases, Journal of Experimental & Clinical Medicine, 2014, 6, 3, 107

    CrossRef

  66. 66
    Kunio Hirano, Liang Tso Sun, Takashi Tada, Principles of Cloning, 2014,

    CrossRef

  67. 67
    Minjung Song, Young-Hoon Kim, Jin-Soo Kim, Hyongbum Kim, The Use of CRISPR/Cas9, ZFNs, and TALENs in Generating Site-Specific Genome Alterations, 2014,

    CrossRef

  68. 68
    Andrew P.W. Gonzales, Jing-Ruey Joanna Yeh, The Use of CRISPR/Cas9, ZFNs, and TALENs in Generating Site-Specific Genome Alterations, 2014,

    CrossRef

  69. 69
    Divya Rajamohan, Elena Matsa, Spandan Kalra, James Crutchley, Asha Patel, Vinoj George, Chris Denning, Current status of drug screening and disease modelling in human pluripotent stem cells, BioEssays, 2013, 35, 3
  70. 70
    Jia Yong Tan, Gopu Sriram, Abdul Jalil Rufaihah, Koon Gee Neoh, Tong Cao, Efficient Derivation of Lateral Plate and Paraxial Mesoderm Subtypes from Human Embryonic Stem Cells Through GSKi-Mediated Differentiation, Stem Cells and Development, 2013, 22, 13, 1893

    CrossRef

  71. 71
    Su Mi Choi, Yonghak Kim, Joong Sup Shim, Joon Tae Park, Rui-Hong Wang, Steven D. Leach, Jun O. Liu, Chuxia Deng, Zhaohui Ye, Yoon-Young Jang, Efficient drug screening and gene correction for treating liver disease using patient-specific stem cells, Hepatology, 2013, 57, 6
  72. 72
    Wei Yan, Cory Smith, Linzhao Cheng, Expanded activity of dimer nucleases by combining ZFN and TALEN for genome editing, Scientific Reports, 2013, 3,

    CrossRef

  73. 73
    Alisa Dong, Stefano Rivella, Laura Breda, Gene therapy for hemoglobinopathies: progress and challenges, Translational Research, 2013, 161, 4, 293

    CrossRef

  74. 74
    Sivaprakash Ramalingam, Viktoriya London, Karthikeyan Kandavelou, Liudmila Cebotaru, William Guggino, Curt Civin, Srinivasan Chandrasegaran, Generation and Genetic Engineering of Human Induced Pluripotent Stem Cells Using Designed Zinc Finger Nucleases, Stem Cells and Development, 2013, 22, 4, 595

    CrossRef

  75. 75
    Keiki Kumano, Shunya Arai, Mineo Kurokawa, Generation of iPS cells from normal and malignant hematopoietic cells, International Journal of Hematology, 2013, 98, 2, 145

    CrossRef

  76. 76
    David J. Segal, Joshua F. Meckler, Genome Engineering at the Dawn of the Golden Age, Annual Review of Genomics and Human Genetics, 2013, 14, 1, 135

    CrossRef

  77. 77
    James M. Kelley, George Q. Daley, Hematopoietic defects and iPSC disease modeling: Lessons learned, Immunology Letters, 2013, 155, 1-2, 18

    CrossRef

  78. 78
    Valentina Spinelli, Pascale V. Guillot, Paolo De Coppi, Induced pluripotent stem (iPS) cells from human fetal stem cells (hFSCs), Organogenesis, 2013, 9, 2, 101

    CrossRef

  79. 79
    Susan Hunt, Joseph Alisky, Inpatient Management of Sickle Cell Disease, Hospital Medicine Clinics, 2013, 2, 2, e247

    CrossRef

  80. 80
    Zita Garate, Brian R. Davis, Oscar Quintana-Bustamante, Jose C. Segovia, New Frontier in Regenerative Medicine: Site-Specific Gene Correction in Patient-Specific Induced Pluripotent Stem Cells, Human Gene Therapy, 2013, 24, 6, 571

    CrossRef

  81. 81
    Pavel Simara, Jason A. Motl, Dan S. Kaufman, Pluripotent stem cells and gene therapy, Translational Research, 2013, 161, 4, 284

    CrossRef

  82. 82
    Xiu-ling Xu, Fei Yi, Hui-ze Pan, Shun-lei Duan, Zhi-chao Ding, Guo-hong Yuan, Jing Qu, Hai-chen Zhang, Guang-hui Liu, Progress and prospects in stem cell therapy, Acta Pharmacologica Sinica, 2013, 34, 6, 741

    CrossRef

  83. 83
    Yingsha Zhang, ChangHui Pak, Yan Han, Henrik Ahlenius, Zhenjie Zhang, Soham Chanda, Samuele Marro, Christopher Patzke, Claudio Acuna, Jason Covy, Wei Xu, Nan Yang, Tamas Danko, Lu Chen, Marius Wernig, Thomas C. Südhof, Rapid Single-Step Induction of Functional Neurons from Human Pluripotent Stem Cells, Neuron, 2013, 78, 5, 785

    CrossRef

  84. 84
    David G Ousterout, Pablo Perez-Pinera, Pratiksha I Thakore, Ami M Kabadi, Matthew T Brown, Xiaoxia Qin, Olivier Fedrigo, Vincent Mouly, Jacques P Tremblay, Charles A Gersbach, Reading Frame Correction by Targeted Genome Editing Restores Dystrophin Expression in Cells From Duchenne Muscular Dystrophy Patients, Molecular Therapy, 2013, 21, 9, 1718

    CrossRef

  85. 85
    Anne B.C. Cherry, George Q. Daley, Reprogrammed Cells for Disease Modeling and Regenerative Medicine, Annual Review of Medicine, 2013, 64, 1, 277

    CrossRef

  86. 86
    Laura Ordovás, Yonsil Park, Catherine M. Verfaillie, Stem cells and liver engineering, Biotechnology Advances, 2013, 31, 7, 1094

    CrossRef

  87. 87
    Basma F Benabdallah, Arnaud Duval, Joel Rousseau, Pierre Chapdelaine, Michael C Holmes, Eli Haddad, Jacques P Tremblay, Christian M Beauséjour, Targeted Gene Addition of Microdystrophin in Mice Skeletal Muscle via Human Myoblast Transplantation, Molecular Therapy — Nucleic Acids, 2013, 2, 1, e68

    CrossRef

  88. 88
    C. Zhu, A. Gupta, V. L. Hall, A. L. Rayla, R. G. Christensen, B. Dake, A. Lakshmanan, C. Kuperwasser, G. D. Stormo, S. A. Wolfe, Using defined finger-finger interfaces as units of assembly for constructing zinc-finger nucleases, Nucleic Acids Research, 2013, 41, 4, 2455

    CrossRef

  89. 89
    Thomas Gaj, Charles A. Gersbach, Carlos F. Barbas, ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering, Trends in Biotechnology, 2013, 31, 7, 397

    CrossRef

  90. 90
    Ahmad S. Khalil, Timothy K. Lu, Caleb J. Bashor, Cherie L. Ramirez, Nora C. Pyenson, J. Keith Joung, James J. Collins, A Synthetic Biology Framework for Programming Eukaryotic Transcription Functions, Cell, 2012, 150, 3, 647

    CrossRef

  91. 91
    Pablo Perez-Pinera, David G Ousterout, Charles A Gersbach, Advances in targeted genome editing, Current Opinion in Chemical Biology, 2012, 16, 3-4, 268

    CrossRef

  92. 92
    Ciaran M. Lee, Rowan Flynn, Jennifer A. Hollywood, Martina F. Scallan, Patrick T. Harrison, Correction of the ΔF508 Mutation in the Cystic Fibrosis Transmembrane Conductance Regulator Gene by Zinc-Finger Nuclease Homology-Directed Repair, BioResearch Open Access, 2012, 1, 3, 99

    CrossRef

  93. 93
    David L. Digiusto, Hans-Peter Kiem, Current translational and clinical practices in hematopoietic cell and gene therapy, Cytotherapy, 2012, 14, 7, 775

    CrossRef

  94. 94
    Stacey E Wirt, Matthew H Porteus, Development of nuclease-mediated site-specific genome modification, Current Opinion in Immunology, 2012, 24, 5, 609

    CrossRef

  95. 95
    Megumu K. Saito, Akira Niwa, Disease-associated iPS cell lines representing hematological and immunological disorders, Inflammation and Regeneration, 2012, 32, 4, 171

    CrossRef

  96. 96
    Weiqi Zhang, Zhichao Ding, Guang-Hui Liu, Evolution of iPSC disease models, Protein & Cell, 2012, 3, 1, 1

    CrossRef

  97. 97
    Rickie Patani, Siddharthan Chandran, Experimental and Therapeutic Opportunities for Stem Cells in Multiple Sclerosis, International Journal of Molecular Sciences, 2012, 13, 12, 14470

    CrossRef

  98. You have free access to this content98
    Li-Tao Cheng, Liang-Tso Sun, Takashi Tada, Genome editing in induced pluripotent stem cells, Genes to Cells, 2012, 17, 6
  99. 99
    Te Liu, Gang Zou, Yongtao Gao, Xinrong Zhao, Hui Wang, Qin Huang, Lizhen Jiang, Lihe Guo, Weiwei Cheng, High Efficiency of Reprogramming CD34+Cells Derived from Human Amniotic Fluid into Induced Pluripotent Stem Cells withOct4, Stem Cells and Development, 2012, 21, 12, 2322

    CrossRef

  100. 100
    Elena Matsa, Chris Denning, In Vitro Uses of Human Pluripotent Stem Cell-Derived Cardiomyocytes, Journal of Cardiovascular Translational Research, 2012, 5, 5, 581

    CrossRef

  101. 101
    F. Soldner, R. Jaenisch, iPSC Disease Modeling, Science, 2012, 338, 6111, 1155

    CrossRef

  102. 102
    Lukas E. Dow, Scott W. Lowe, Life in the Fast Lane: Mammalian Disease Models in the Genomics Era, Cell, 2012, 148, 6, 1099

    CrossRef

  103. 103
    Tamer T Onder, George Q Daley, New lessons learned from disease modeling with induced pluripotent stem cells, Current Opinion in Genetics & Development, 2012, 22, 5, 500

    CrossRef

  104. 104
    Zhaohui Ye, Bin-Kuan Chou, Linzhao Cheng, Promise and challenges of human iPSC-based hematologic disease modeling and treatment, International Journal of Hematology, 2012, 95, 6, 601

    CrossRef

  105. 105
    Benjamin Groß, Erik Pittermann, Dirk Reinhardt, Tobias Cantz, Jan-Henning Klusmann, Prospects and Challenges of Reprogrammed Cells in Hematology and Oncology, Pediatric Hematology-Oncology, 2012, 29, 6, 507

    CrossRef

  106. 106
    Ning Sun, Zhanar Abil, Huimin Zhao, Recent advances in targeted genome engineering in mammalian systems, Biotechnology Journal, 2012, 7, 9
  107. 107
    Xiuling Xu, Jing Qu, Keiichiro Suzuki, Mo Li, Weizhou Zhang, Guang-Hui Liu, Juan Carlos Izpisua Belmonte, Reprogramming based gene therapy for inherited red blood cell disorders, Cell Research, 2012, 22, 6, 941

    CrossRef

  108. 108
    Emily Riehm Meier, Jeffery L. Miller, Sickle Cell Disease in Children, Drugs, 2012, 1

    CrossRef

  109. 109
    J. Keith Joung, Jeffry D. Sander, TALENs: a widely applicable technology for targeted genome editing, Nature Reviews Molecular Cell Biology, 2012, 14, 1, 49

    CrossRef

  110. 110
    Katja G Weinacht, Patrick M Brauer, Kerstin Felgentreff, Alex Devine, Andrew R Gennery, Silvia Giliani, Waleed Al-Herz, Axel Schambach, Juan Carlos Zúñiga-Pflücker, Luigi D Notarangelo, The role of induced pluripotent stem cells in research and therapy of primary immunodeficiencies, Current Opinion in Immunology, 2012, 24, 5, 617

    CrossRef

  111. 111
    Howard C.H. Chow, Alice M.S. Cheung, Ronald A. Li, Camie W.Y. Chan, Eric C.W. So, Anskar Y.H. Leung, The use of human induced pluripotent stem cells (hiPSC) for modeling blood disorders, Drug Discovery Today: Disease Models, 2012, 9, 4, e185

    CrossRef

  112. 112
    Rickie Patani, Christopher R. Sibley, Siddharthan Chandran, Jernej Ule, Using human pluripotent stem cells to study post-transcriptional mechanisms of neurodegenerative diseases, Brain Research, 2012, 1462, 129

    CrossRef

  113. 113
    C.-J. Chang, E. E. Bouhassira, Zinc-finger nuclease-mediated correction of  -thalassemia in iPS cells, Blood, 2012, 120, 19, 3906

    CrossRef

  114. 114
    Tianjian Li, Jason Gustin, Mahesh Dodla, Ian Lyons, Human Stem Cell Manual, 2012,

    CrossRef

  115. 115
    Mo Li, Keiichiro Suzuki, Jing Qu, Preeti Saini, Ilir Dubova, Fei Yi, Jungmin Lee, Ignacio Sancho-Martinez, Guang-Hui Liu, Juan Carlos Izpisua Belmonte, Efficient correction of hemoglobinopathy-causing mutations by homologous recombination in integration-free patient iPSCs, Cell Research, 2011, 21, 12, 1740

    CrossRef

  116. 116
    Huize Pan, Weiqi Zhang, Weizhou Zhang, Guang-Hui Liu, Find and replace: editing human genome in pluripotent stem cells, Protein & Cell, 2011, 2, 12, 950

    CrossRef

  117. 117
    Moira A McMahon, Meghdad Rahdar, Matthew Porteus, Gene editing: not just for translation anymore, Nature Methods, 2011, 9, 1, 28

    CrossRef

  118. 118
    Marc C. Hansel, Julio C. Davila, Massoud Vosough, Roberto Gramignoli, Kristen J. Skvorak, Kenneth Dorko, Fabio Marongiu, William Blake, Stephen C. Strom, The Use of Induced Pluripotent Stem Cells for the Study and Treatment of Liver Diseases, Current Protocols in Toxicology,